NGVT - Company ID 0001653477
The table below shows Ingevity Corp's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $1.17B | $1.20B | $1.22B | $1.67B | $1.39B | $1.22B |
| Cost of revenue | $706.10M | $735.30M | $770.50M | $1.10B | $878.70M | $750.60M |
| Gross profit | $461.50M | $464.80M | $445.00M | $570.10M | $512.80M | $465.50M |
| R&D | $28.40M | $24.50M | $25.40M | $30.30M | $26.30M | $22.60M |
Ingevity Corp reported annual revenue of $1.17B for fiscal year 2025. That is down 2.7% from $1.20B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $908.30M (FY 2016) to $1.17B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $171.20M |
| $157.80M |
| $161.80M |
| $198.80M |
| $179.30M |
| $149.40M |
| Operating income | $418.70M | $425.90M | $423.20M | $452.60M | $422.20M | $397.90M |
| Income tax | $8.20M | -$19.10M | $24.20M | $58.00M | $44.70M | $53.70M |
| Net income | -$167.10M | -$430.30M | -$5.40M | $211.60M | $118.10M | $181.40M |
| EPS (diluted) | -$4.61 | -$11.85 | -$0.15 | $5.50 | $2.95 | $4.37 |